ZBH · News · 20260805N

Revenue Performance and Mix

ZIMMER BIOMET HOLDINGS, INC. · 2026-08-05 · Importance 31 · Surprise 32

Second-quarter 2026 net sales increased 4.8% year over year to $2.177 billion, including 4.7% growth on a constant-currency basis and 4.0% organic constant-currency growth. U.S. technology revenue increased 53%, while strong U.S. hip sales and growth in technology and data supported the quarter. Knee performance, particularly in China, and trauma/restorative therapies remained weaker, creating a mixed segment contribution. The S.E.T. business also contributed to growth during the quarter.

Key facts

• Zimmer Biomet reported revenue of $2.177 billion in Q2 2026, surpassing estimates by over $21 million source
• Second quarter net sales: $2.177 billion, increased 4.8% on a reported basis, 4.7% on a constant currency basis and 4.0% on an organic constant currency basis source
• Net sales were up 4.8% year-on-year to $2.18 billion in Q2 CY2026 source
• GuruFocus reported net sales of $2.177 billion and 4% organic constant currency growth driven primarily by robust US performance in the hips segment and technology source
• Reported 4% organic constant currency growth in Q2 2026 source